Currently tracking 28 active AI roles, down 25% versus the prior 4 weeks. Primary focus: Agent · Engineering. Salary range $58k–$345k (avg $175k).
Eli Lilly currently has 36 active AI-related job listings. The majority of these roles, 56%, are focused on agents, with data-related positions making up another 28%. Engineering is the most frequent function for these hires. The company is primarily hiring in the United States and India. Frequent technology tags include agent orchestration, RAG, and model serving, indicating a focus on building and deploying AI systems.
Eli Lilly currently has 36 active AI-related roles in our index. The most common open titles are: Director, Discovery Bioinformatics Oncology (2), Advisor - Agent Research, Advisor - Antibody Developability Validation & Benchmarking, Advisor - Data Architect, Data Foundry, Advisor - Lab Automation Software Engineer. Most positions are in Engineering and Research.
Eli Lilly's active AI hiring is concentrated in: agents (53%), data (25%), application (8%). These categories follow a seven-stage AI lifecycle: data, pre-training, post-training, serving infrastructure, agents, evaluation, and application.
Eli Lilly is hiring AI talent in: United States (29 roles), India (7 roles).
Job postings at Eli Lilly most frequently reference: agent orchestration, rag, model serving, llm observability, vector db.
In the past 30 days, Eli Lilly has posted 12 new AI-related roles. That is a -48% change versus the prior 30 days (23 → 12).
| Title | Stage | AI score |
|---|---|---|
| Health Technology Assessment (HTA) & PRA Lead, KSA This role focuses on Health Technology Assessment (HTA) and Pricing, Reimbursement & Access (PRA) within the Saudi Arabian healthcare market. The Lead will develop economic models, evidence packages, and HTA content for payer submissions, and design/deliver training programs for PRA and Key Account Management (KAM) teams to improve their economic fluency and payer engagement. The goal is to accelerate access for Lilly's innovations and sustain access for existing products in a maturing reimbursement environment. | — | 0 |